Skip to main content
Top
Published in: BMC Neurology 1/2021

Open Access 01-12-2021 | Anemia | Case report

Reversible cerebral vasoconstriction syndrome with cardiac involvement during treatment for iron deficiency anemia: caser report

Authors: Kenya Oguchi, Kazuhiro Fukushima, Akinori Nakamura, Yo-ichi Takei

Published in: BMC Neurology | Issue 1/2021

Login to get access

Abstract

Background

The diagnosis and therapy of reversible cerebral vasoconstriction syndrome (RCVS) tends to focus on neurological symptoms, but less attention has been paid the occurrence of extracerebral lesion such as the myocardium.

Case presentation

A 40-year-old woman taking iron supplements for iron deficiency anemia due to menorrhagia had suffered from a thunderclap headache and seizure. Brain magnetic resonance imaging revealed high-intensity lesions bilaterally in the cerebellar and cerebral hemispheres. Her symptoms once subsided with steroids and anticonvulsant therapy; however, she experienced a severe headache again while bathing and was transferred to our hospital. Based on the clinical course and imaging data, she was diagnosed as having RCVS triggered by a rapid improvement of anemia. At the same time, she had cardiac involvement revealed by electro and echocardiographs despite without chest symptoms. After the administration of a calcium channel blocker and nitrite, her cerebral and cardiac involvements were rapidly improved.

Conclusions

The case presented RCVS with transient myocardial damage. With RCVS, we should always pay attention to the complication of extracerebral lesions.
Literature
1.
go back to reference Ducros A. Reversible cerebral vasoconstriction syndrome. Lancet Neurol. 2012;11:906–17.CrossRef Ducros A. Reversible cerebral vasoconstriction syndrome. Lancet Neurol. 2012;11:906–17.CrossRef
2.
go back to reference Singhal AB, Haji-Ali RA, Topcuoglu MA, Fok J, Bena J, Yang D, Calabrese LH. Reversible cerebral vasoconstriction syndrome: analysis of 139 cases. Arch Neurol. 2011;68:1005–12.CrossRef Singhal AB, Haji-Ali RA, Topcuoglu MA, Fok J, Bena J, Yang D, Calabrese LH. Reversible cerebral vasoconstriction syndrome: analysis of 139 cases. Arch Neurol. 2011;68:1005–12.CrossRef
3.
go back to reference Dou YH, Fuh JL, Chen SP, Wang SJ. Reversible cerebral vasoconstriction syndrome after blood transfusion. Headache. 2014;54:736–44.CrossRef Dou YH, Fuh JL, Chen SP, Wang SJ. Reversible cerebral vasoconstriction syndrome after blood transfusion. Headache. 2014;54:736–44.CrossRef
4.
go back to reference Miller TR, Shivashankar R, Mossa-Basha M, Gandhi D. Reversible cerebral vasoconstriction syndrome, part 1: epidemiology, pathogenesis, and clinical course. Am J Neuroradiol. 2015;36:1392–1329.CrossRef Miller TR, Shivashankar R, Mossa-Basha M, Gandhi D. Reversible cerebral vasoconstriction syndrome, part 1: epidemiology, pathogenesis, and clinical course. Am J Neuroradiol. 2015;36:1392–1329.CrossRef
5.
go back to reference Dakay K, Kaur G, Gulko E, Santarelli J, Bowers C, Mayer SA, Gandhi CD, Al-Mufti F. Reversible cerebral vasoconstriction syndrome and dissection in the setting of COVID-19 infection. J Stroke Cerebrovasc Dis. 2010;29:105011.CrossRef Dakay K, Kaur G, Gulko E, Santarelli J, Bowers C, Mayer SA, Gandhi CD, Al-Mufti F. Reversible cerebral vasoconstriction syndrome and dissection in the setting of COVID-19 infection. J Stroke Cerebrovasc Dis. 2010;29:105011.CrossRef
6.
go back to reference Lopez JI, Holdridge A, Chalela J. Headache and vasculitis. Curr Pain Headache Rep. 2013;17:320.CrossRef Lopez JI, Holdridge A, Chalela J. Headache and vasculitis. Curr Pain Headache Rep. 2013;17:320.CrossRef
7.
go back to reference Gatla N, Annapureddy N, Sequeira W, Jolly M. Posterior reversible encephalopathy syndrome in systemic lupus erythematosus. J Clin Rheumatol. 2013;19:334–40.CrossRef Gatla N, Annapureddy N, Sequeira W, Jolly M. Posterior reversible encephalopathy syndrome in systemic lupus erythematosus. J Clin Rheumatol. 2013;19:334–40.CrossRef
8.
go back to reference Chen SP, Fuh JL, Wang SJ. Reversible cerebral vasoconstriction syndrome: current and future perspectives. Expert Rev Neurother. 2011;11:1265–76.CrossRef Chen SP, Fuh JL, Wang SJ. Reversible cerebral vasoconstriction syndrome: current and future perspectives. Expert Rev Neurother. 2011;11:1265–76.CrossRef
9.
go back to reference John S, Hajj-Ali RA, Min D, Min D, Calabrese LH, Cerejo R, Uchino K. Reversible cerebral vasoconstriction syndrome: Is it more than just cerebral vasoconstriction? Cephalalgia. 2015;35:631–4.CrossRef John S, Hajj-Ali RA, Min D, Min D, Calabrese LH, Cerejo R, Uchino K. Reversible cerebral vasoconstriction syndrome: Is it more than just cerebral vasoconstriction? Cephalalgia. 2015;35:631–4.CrossRef
10.
go back to reference Laeeq R, Berman JS, Khalid U, Lakkis NM, Tabbaa R. Reversible cerebral vasoconstriction syndrome associated with coronary artery vasospasm. Tex Heart Inst J. 2019;46:139–42.CrossRef Laeeq R, Berman JS, Khalid U, Lakkis NM, Tabbaa R. Reversible cerebral vasoconstriction syndrome associated with coronary artery vasospasm. Tex Heart Inst J. 2019;46:139–42.CrossRef
12.
go back to reference Singhal AB, Topcuoglu MA. Glucocorticoid-associated worsening in reversible cerebral vasoconstriction syndrome. Neurology. 2017;88:228–36.CrossRef Singhal AB, Topcuoglu MA. Glucocorticoid-associated worsening in reversible cerebral vasoconstriction syndrome. Neurology. 2017;88:228–36.CrossRef
Metadata
Title
Reversible cerebral vasoconstriction syndrome with cardiac involvement during treatment for iron deficiency anemia: caser report
Authors
Kenya Oguchi
Kazuhiro Fukushima
Akinori Nakamura
Yo-ichi Takei
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2021
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-021-02509-w

Other articles of this Issue 1/2021

BMC Neurology 1/2021 Go to the issue